ESR1 and breast carcinoma: To further determine the role of TET2 in conferring endocrine resistance in human breast cancer cells, we generated a stable TET2 knock-out cell line using the CRISPR-Cas9 system in ERα-positive, luminal breast cancer MCF7 cells.